Sirnaomics Advances STP705 for Squamous Cell Carcinoma In Situ into Late-Stage Clinical Development

HONG KONG, GERMANTOWN, Md. and SUZHOU, China, June 19, 2023 -- (Healthcare Sales & Marketing Network) -- Sirnaomics Ltd. (the "Company"; stock code: 2257, together with its subsidiaries, the "Group" or "Sirnaomics"), a leadin... Biopharmaceuticals, Oncology Sirnaomics, RNAi therapeutics, squamous cell carcinoma
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news